Frederic Lacombe
6Patents
1h-index
16Co-inventors
44Inventor score
Filing activity: Jun 30, 2006 → Sep 7, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9724397B2 | Sustained release formulations comprising very low molecular weight polymers | Human Necessities | 4 | Active |
| US7999061B2 | Catalytic lactide and glycolide (co)polymerization system | Chemistry; Metallurgy | 1 | Active |
| US11786579B2 | Injectable presentations, syringes and compositions with sustained and/or controlled release of lanreotide | Human Necessities | 1 | Active |
| US8236759B2 | GLP-1 pharmaceutical compositions | Human Necessities | 0 | Active |
| US12201674B2 | Injectable presentations, syringes and compositions with sustained and/or controlled release of lanreotide | Human Necessities | 0 | Active |
| US11878157B2 | Syringe-connector device for the separate administration of controlled quantities at least two products in a single injection | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.